Broker Williams Trading has cast doubt on Birkenstocks prospects / Photo: Facebook / Birkenstock
Small Caps·
An analyst does not recommend Birkenstock stock. The brand could lose its premium status
BPs network of gas stations in the U.S. consists of about 8,500 stations / Photo: Karolis Kavolelis / Shutterstock.com
News·
"We need to take a hard look at ourselves": BP has doubled its profits and is selling its "green" business in the U.S.
The market is being supported by strong corporate earnings and continued interest in the technology sector, giving the S&P 500 the opportunity to test its all-time high / Photo: X / NYSE
News·
Morning in New York: S&P 500 on the Verge of New Records
Trump warned that the current negotiations with Iran are the “last chance” to end the war. In Tehran, officials deny that any dialogue with Washington is even taking place / Photo: Alones / Shutterstock
News·
A ship was attacked in the Strait of Hormuz. Trump gave Iran a "last chance" to reach a deal
News·
"The Numbers Don't Matter": What Analysts Will Be Looking for in SpaceX's First Post-IPO Report
News·
Revolut CEO Storonsky Faces Lawsuit Over €350 Million Yacht Purchase
News·
Chinese AI developers have created a "death zone" for Anthropic and OpenAI
Small Caps·
Oninvest Index: Quantum small-caps have lost most of their gains. Is this the end of the rally?
Stock Screener
Buy
Sell
Go to section
Guru Portfolios

Track the investments of top funds and market legends

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Go to section
Small Caps
Green Thumb continues generating profits while many rivals struggle, a Motley Fool analyst argues / Photo: Instagram / gtigrows
Small Caps·
Motley Fool calls Green Thumb the safest pot stock now, citing strong fundamentals
Small Caps·
Biotech Replimune more than doubles after FDA panel OKs skin cancer treatment
Small Caps·
Small caps last week: Cathie Wood’s Scribe bet, deals to acquire Forte Bio and CBIZ
Small Caps·
IT small cap Cycurion soars 500% after landing biggest contract in its history
Small Caps·
+1
·
Apnimed IPO: Sleep apnea drug developer debuts on the Nasdaq
Go to section

Investment and Finance News